NHS Generic Pharmaceuticals - Lenalidomide, Pomalidomide & Thalidomide

NHS England is establishing a national framework for supply of three specialist medicines: lenalidomide, pomalidomide, and thalidomide. The framework runs two years from June 2026, covering three regional NHS procurement hubs, with optional extension to 48 months total.

View on Find a Tender →

Closed9 March 2026, 13:00
Published5 February 2026
Value£34m
Per lot£11m across 3 lots
BuyerNHS England
CategoryHealth & medical
RegionUK-wide

You'll want to look if you are a pharmaceutical wholesaler or manufacturer licensed to distribute lenalidomide, pomalidomide, or thalidomide in the UK

Might not suit a small firm

the contract itself is a large one
it needs coverage across the whole UK

Possible incumbent

Multiple suppliers held the previous Wave 15c generic pharmaceuticals framework; specialist products like these were previously awarded to Mercury Pharmaceuticals, Orifarm UK, and Janssen Cilag in separate 2025 frameworks. Inferred from prior awards to this buyer, not confirmed.